EE714 A De Novo Cost-Effectiveness Model to Evaluate the Real-World Value of Pegcetacoplan in the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration in the United States
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.979
https://www.valueinhealthjournal.com/article/S1098-3015(23)04109-8/fulltext
Title :
EE714 A De Novo Cost-Effectiveness Model to Evaluate the Real-World Value of Pegcetacoplan in the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04109-8&doi=10.1016/j.jval.2023.09.979
First page :
Section Title :
Open access? :
No
Section Order :
10475